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Abstract.  We have investigated the degradation in rat 
liver of two typical endoplasmic reticulum (ER) mem- 
brane proteins, phenobarbital  (PB)-inducible cyto- 
chrome P-450 (P-450[PB]) and NADPH-cytochrome 
P-450 reductase (FP2).  Autolysosomes, almost com- 
pletely free from contamination by the other organelles 
such as ER, were prepared from leupeptin-treated rat 
livers according to the method of Furuno et al. 
(Furuno,  K., T.  Ishikawa,  and K. Kato,  1982, J. Bio- 
chem., 91:1943-1950).  Quantitative immunoblot analy- 
sis showed that these two proteins were found in large 
amounts in the autolysosomes regardless of PB treat- 
ment.  The specific content of P-450 (PB) in the au- 
tolysosomes changed along with that in the micro- 
somes during and after PB treatment,  whereas hardly 
any P-450(PB) was detected in the cytosol fraction 
throughout the experiment.  We also found a marked 
increase in the autolysosomal proteins 3 d after cessa- 
tion of PB treatment when microsomal proteins are 
degraded most rapidly.  Ferritin immunoelectron mi- 
croscopy revealed directly that when the limiting 
membranes of the premature autolysosomes were par- 
tially broken the smooth vesicles segregated within the 
autolysosomes were heavily stained with ferritin anti- 
P-450(PB) conjugates. Thus,  for the first time, we 
could present convincing evidence that P-450(PB) and 
FP2 are segregated to be degraded in the autolysosomes. 
C 
YTOCHROME P-450 (P-450) m, together with NADPH- 
cytochrome P-450  reductase (FP2),  constitutes  the 
microsomal monooxygenase system in a hepatic cell 
that plays an important function in the oxidation of numerous 
endogeneous and xenobiotic compounds. It has been well- 
established  that multiple  forms of P-450 and specific forms 
of P-450  exist that  are inducible  by various drugs such as 
phenobarbital  (PB), 3-methylcholanthrene,  and [I-naphtofla- 
vone. For example,  PB treatment  causes rapid increases  in 
the PB-inducible P-450 (P-450[PB])  and FP2 accompanied 
by remarkable proliferation  of smooth endoplasmic reticu- 
lum (ER) (2,  11, 23). 
Although  in recent years many efforts have been made to 
clarify the mechanism for biosynthesis and drug induction 
of the microsomal monooxygenase enzymes (1, 5, 7, 9,  19, 
20), the mechanism for their degradation  is still poorly un- 
derstood. The concentration of any enzyme in a cell is deter- 
mined by-the equilibrium between its biosynthesis and degra- 
dation, and it is very important  to investigate the molecular 
and cellular mechanisms  responsible for the degradation  of 
the microsomal monooxygenase enzymes. 
The turnover rate of several forms of P-450, together with 
the other microsomal proteins,  has been previously reported 
(18, 21, 24, 26, 27). The wide differences  in their  half-lives 
1.  Abbreviations  used  in  this paper:  ER,  endoplasmic reticulum; FP2, 
NADPH-cytochrome P-450  reductase;  G-6-Pase,  glucose-6-phosphatase; 
P-450, cytochrome P-450;  PB,  phenobarbital; P-450(PB),  major form of 
cytochrome P-450 in hepatic microsomes of PB-treated rats. 
has led some investigators to deny the important  role of the 
autolysosomes in  the degradation  of microsomal proteins 
(21, 24, 26, 27). Bolender and Weibel (3), however, showed 
by morphometric analysis that the removal of PB-induced ex- 
cess ER membranes  was associated with  increase  in  au- 
tophagic activity. We have previously shown that a decrease 
in  the  contents  of  microsomal  proteins  and  P-450(PB) 
parallels  an increase  in the number of the autophagic  vacu- 
oles after the cessation of PB treatment (15). These results 
suggested  the concomitant  removal of the proliferated  ER 
membranes and P-450(PB)  via the autolysosomes. 
No direct evidence, however, has been presented so far to 
show that microsomal enzymes such as P-450 and FP2 are 
indeed segregated and degraded in the autolysosomes. In this 
paper we isolated autolysosomes from leupeptin-treated  rat 
livers and showed by quantitative immunoblot and immuno- 
electron  microscopic  analyses  that  the  autolysosomes do 
contain  large amounts  of P-450(PB)  and FP2 molecules to 
be degraded there. 
Materials and Methods 
Materials 
PB was purchased from Sanko Seiyaku Kogyo Co., Ltd., Tokyo. mI-La- 
beled protein A (30 mCi/mg protein) was obtained from Amersham Interna- 
tional, England. Leupeptin was purchased from the Protein Research Foun- 
dation, Osaka,  and Percoll and density marker beads were purchased from 
Pharmacia Fine Chemicals,  Uppsala.  All other chemicals were of the 
highest purity commercially available. 
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Male Sprague-Dawley rats (m150 g) were fed ad libitum on laboratory chow 
and were given an intraperitoneal injection of PB (80 mg/kg body wt) once 
a day for 4 d. 
Cell Fractionation 
The autolysosome fraction was prepared from both PB-treated and un- 
treated rats according to Furuno et al. (6) with a slight modification in that 
the PercoU density gradient centrifugation was performed twice for the 
purification. 
Microsome fraction was prepared from the supernatant of the second 
centrifugation at 1,700 g for 10 min. After further centrifugation at 10,000 
g for 20 min, the supernatant was centrifuged at 110,000 g for 90 min, and 
the resultant pellet was used as the microsome fraction. To obtain the cytosol 
fraction, the resultant supernatant was further centrifuged at 110,000 g for 
5h. 
Preparation of  Antibodies Against 
P-450(PB) and FP2 
P-450(PB) and FP2 were purified from liver microsomes of PB-treated rats 
according to the procedures described by Masaki et al. (15) and Yasukochi 
and Masters (30), respectively. 
Antisera against these two antigens were elicited in rabbits, and the IgG 
fractions of the antisera were purified by repeated ammonium sulfate frac- 
tionation followed by DEAE cellulose column chromatography (15). The 
specific antibody was purified by affinity chromatography using Sepharose 
4B conjugated with purified P-450(PB) or FP2. 
Immunoblot Procedures 
SDS PAGE was performed according to the procedures of Laemmli (12). 
Immunoblot with ~25I-protein A was done according to Burnette (4). The 
concentrations of affinity purified anti-P-450(PB) or FP2 antibody were 20 
~tg/ml. For quantitative assay, the nitrocellulose was carefully aligned with 
the autoradiogram and the bands corresponding to P-450(PB) or FP2 were 
excised and counted in an autogamma spectrometer (model 5780;  Packard 
Instrument Co., Inc., United Technologies, Downers Grove, IL). A stan- 
dard curve based on purified P-450(PB) or FP2 run in the adjacent lanes 
was found to be linear up to 200 ng of each antigen. 
Electron Microscopy 
The autolysosome fraction was centrifuged at 15,000 g for 15 min. The pellet 
was fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4, 
and postfixed in 1.0% osmium tetroxide in the same buffer, dehydrated, and 
embedded in Epon 812. The thin sections were cut and observed under an 
Hitachi electron microscope (model HU-11). 
Ferritin Immunoelectron Microscopy 
Ferritin antibody conjugates against P-450(PB) with the molar ratio of IgG 
to ferritin ('~hl) were prepared as previously described (16), and were con- 
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Figure 1. Purification of autolysosomes by Percoll density gradient 
centrifugation  from crude lysosome fractions.  Liver crude  lyso- 
some fractions prepared from leupeptin-untreated  (A) and treated 
(B) rats were suspended in 30 ml of iso-osmotic Percoll at a density 
of 1.10 g/ml. After Percoll density gradient centrifugation,  fractions 
of 1 ml each were collected and analyzed for marker enzymes; acid 
phosphatase  (o),  G-6-Pase  (e),  and cytochrome oxidase (A) ac- 
tivities. 
were prepared in the same way by coupling ferritin with IgG from nonim- 
munized rabbits. 
An aliquot of the rat liver autolysosomes (500 Ixg protein) was incubated 
for 30 min at 4°C with 1(30 txl of either antibody conjugates or control con- 
jugates. After incubation, the specimens were washed repeatedly by cen- 
trifugation and processed for electron microscopic observation as described 
above. 
Analytical Procedures 
FP2 was assayed as described by Omura and Takesue  (22).  Glucose-6- 
phosphatase (G-6-Pase), cytochrome oxidase, cathepsin D, and acid phos- 
phatase were determined by the methods of Leskes et al. (13), Wharton and 
Tzagoloff (31), Yamamoto et al. (28), and Pricer and Ashwell (25), respec- 
tively. Protein was measured by the method of Lowry et al. (14) using BSA 
Table L Marker Enzyme Activities in Liver Homogenate (Homog), Autolysosomes (AI), and Microsome (Ms) 
Fractions Prepared from PB-treated and Untreated Rats 
Without  PB treatment  With PB treatment 
Cell fractions  Homog  A1  Ms  Homog  AI  Ms 
G-6-Pase*  72.2  +  9.5  2.1  +  2.0  300.1  +  61.4  53.9  +  8.7  1.1  +  0.9 
FP2*  47.2  5:7.1  0.7  5:0.6  211.0  5:20.0  74.2  +  15.7  0.3  5:0.2 
Cytochrome Oxidase§  0.66  +  0.07  0.07  5:0.05  -  0.51  5:0.04  0.06  +  0.01 
Cathepsin DII  1.4  5:0.2  27.6  5:13.1  -  1.4  5:0.2  21.0  5:4.5 
Acid Phosphatase*  25.0  5:1.7  323.2  5:162.0  -  19.5  5:2.7  257.4  +  79.5 
252.0  +  53.2 
359.1  +  50.5 
* moles of inorganic  phosphate liberated/min/mg protein. 
$ nmoles of cytochrome C reduced/min/mg protein. 
§ p.moles of eytochrome C oxidized/min/mg protein. 
II gg of Tyrosine liberated/min/mg  protein. 
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density gradient markers from Pharmacia Fine Chemicals. 
Results 
Purification of  Autolysosomes by PercoU 
Density Gradient Centrifugation 
Fig.  1 shows the distribution patterns of three marker en- 
zymes after the first Percoll density gradient centrifugation. 
Cytochrome  oxidase, a mitochondrial marker, was recovered 
in fractions with a density of 1.06-1.12 g/mL G-6-Pase, an 
ER marker enzyme, was recovered in fractions of lower den- 
sity (1.05-1.08  g/ml) than those of cytochrome oxidase and 
never recovered in the fractions of  heavier density. Leupeptin 
did not change the distribution patterns of either cytochrome 
oxidaso and G-6-Pase. Acid phosphatase, a lysosomal marker 
enzyme, was recovered in fractions with a density of 1.05- 
1.09 g/ml in the control rat. Upon treatment with leupeptin, 
another sharp peak of acid phosphatase activity appeared at 
the heavier region 0.13-1.15  g/mi), which was clearly sepa- 
rated  from the mitochondria and  ER markers.  The latter 
fraction was further subjected to the second Percoll density 
gradient centrifugation to purify the autolysosomes. 
Biochemical and Morphological Characterization 
of  the Purified Au  tolysosomes 
Table I shows the several marker enzyme activities of the au- 
tolysosome and microsome fractions from PB-treated and 
untreated rats.  As reported by various investigators (7,  11, 
20), PB treatment caused an increase in the microsomal FP2 
activity (-,twofold). The enzymatic profiles in the autoly- 
sosome fraction from PB-treated and  untreated rats  were 
nearly identical.  As reported by Furuno et al.  (6), the au- 
tolysosome fractions were enriched 15-20-fold and 13-fold in 
cathepsin D and acid phosphatase activities, respectively. In 
contrast, the activities of two ER marker enzymes, G-6-Pase 
and FP2, were scarcely detectable in these fractions, as ex- 
pected from the results shown in Fig. 1. The specific activity 
of cytochrome oxidase in  the autolysosome fractions was 
~10%  of those of the homogenates. These results indicate 
a  good  separation  of autolysosomes  from  ER  and  mito- 
chondria. 
The purity of the autolysosome fraction was confirmed by 
electron microscopic observations as shown in Fig. 2. The 
fraction consisted predominantly of autolysosomes, 99 % of 
which were mature autolysosomes containing electron dense 
materials and 1% that were premature autolysosomes con- 
taining apparently intact cell organelles such as mitochon- 
dria and ER (Fig. 8). The contamination of the other organ- 
elles, especially of ER membranes, was hardly detectable. 
Immunochemical Detection of  P-450(PB) 
and FP2 in the Liver Microsomes from PB-treated 
and Untreated Rats 
We prepared specific antibodies against P-450(PB) and FP2. 
Figure 2. Electron micrograph of the purified autolysosome fraction. The autolysosome fraction consisted entirely of autolysosomes except 
for a few mitochondria shown by small arrows. Bar, 2.5  ltm. 
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noblot analyses of  the microsomal 
proteins from PB-treated and un- 
treated rat livers. The microsome 
fractions  from  PB-treated  (A, 
lane 1; B, lanes 1 and 4) and un- 
treated (.4, lane 2; B; lanes 2 and 
5)  rat  livers were  separated on 
SDS PAGE  and stained with Coo- 
massie Brilliant  Blue (A), or trans- 
ferred to a  nitrocellulose sheet, 
reacted with anti-P-450(PB) (B, 
lanes 1 and 2) and anti-FP2 (B, 
lanes 4 and 5) antibodies, respec- 
tively, and visualized by autoradi- 
ography after labeling with  1251- 
protein A. Purified P-450(PB) (A, 
lane 3; B, lane 3) and FP2  (A, 
lane 4; B, lane 6) were analyzed 
by SDS PAGE and  immunoblot 
simultaneously. Numbers  in the 
center are molecular mass in kilo- 
daltons. 
The specificity of the antibody preparations was tested by 
Ouchterlony double diffusion tests (data not shown) and fur- 
ther assessed by an immunoblot analysis. In the microsome 
fraction from PB-treated rats a single band at 53 kD corre- 
sponding to P-450(PB) was detected and no other component 
was labeled (Fig. 3). This result indicates the monospecific- 
ity of the  antibody against  P--450(PB).  Although  another 
band at "o50 kD was detected in the microsome fraction from 
PB-untreated rats, the ratio of the two bands varied with the 
microsome preparations. In addition, when poly (A)-contain- 
ing mRNA prepared from PB-untreated rats was translated 
in a cell free system, the anti-P-450(PB) antibody precipi- 
tated only a single-labeled protein band at 53 kD correspond- 
ing to P-450(PB) (data not shown). These observations sug- 
gest that P-450(PB) in the microsomes of PB-untreated rats 
(53 kD) is easily degraded to "o50-kD component. An alter- 
native possibility is that the "o50-kD component is a minor 
form of microsomal P-450 that cross-reacts with the anti- 
body against P-450(PB). 
It is quite evident from Fig. 3 that PB treatment dramati- 
cally increased P-450(PB). Fig. 3  also demonstrates that a 
single-labeled protein corresponding to FP2  in  molecular 
mass (78 kD) was detected with the specific anti-FP2 anti- 
body, indicating the monospecificity  of  this antibody. The in- 
duction of FP2 upon PB treatment was also confirmed. 
Detection of  P-450(PB) and FP2 in 
the Autolysosome l~ractions 
Next we tried to detect whether or not P-450(PB) was present 
in the autolysosomes using the following experiment. The 
gradients after the first Percoll density gradient centrifuga- 
tion were analyzed for acid phosphatase activity and for the 
immunoblot. Fig. 4  shows the distribution patterns of acid 
phosphatase and P-450(PB) in the autolysosomes fractions 
with a density range of 1.13-1.15 g/ml.  As shown in Fig. 4 
A,  the distribution pattern of P-450(PB) almost coincided 
with that  of acid phosphatase.  In  contrast,  no  significant 
amount of acid phosphatase and P-450(PB) was detectable in 
the  same  fraction  prepared  from  leupeptin-untreated  rat 
liver (Fig. 4 B). 
This result, together with those obtained by enzymatic and 
morphological  characterizations of the  purified autolyso- 
somes,  indicates  clearly that  P-450(PB)  recovered in  the 
autolysosome fraction cannot be attributed to the contami- 
nating ER membranes. The immunoblot analysis of the auto- 
lysosome fractions prepared from PB-treated and untreated 
rats showed that both P-450(PB) and FP2 were detected by 
the corresponding specific antibodies (Fig. 5). Although the 
53-kD band together with the "o50-kD band was detected in 
the autolysosomes from PB-untreated rats, the "o50-kD form 
was the main component in the autolysosomes fraction as 
shown in Fig. 5 B, suggesting that conversion of P-450(PB) 
in PB-untreated rats from 53 to 50 kD might be accelerated 
in the autolysosomes. Fig. 5 B also indicates that PB treat- 
ment produced an increase in the amounts of both P-450(PB) 
and FP2 in the autolysosomes. 
Quantitation of  P-450(PB) and FP2 in the 
Microsome, Autolysosome, and Cytosol Fractions 
The amounts of P-450(PB) and FP2 in the microsome and 
autolysosome fractions  can  be  estimated  as  described  in 
Materials and Methods. The results of such quantitations are 
listed in Table I/. The specific contents of the two proteins 
in the microsomes from PB-untreated rats were "o40 pmol/ 
mg protein. Upon PB treatment, the amounts of P-450 (PB) 
and FP2 in microsomes increased ,o15- and 2.5-fold, respec- 
tively, consistent with many previous reports (1, 2, 5, 7, 8, 
11,  15,  20).  Coincident with their increases in the micro- 
somes, P-450(PB) and FP2 segregated in the autolysosomes 
increased 10- and twofold, respectively. The amounts of the 
two ER proteins recovered in the autolysosomes were "o5 % 
of those in the microsomes. 
The Journal of Cell Biology, Volume 104,  1987  1210 Figure 4. Distribution patterns of acid phosphatase and P-450(PB) 
in the autolysosome fraction obtained by Percoll density gradient 
centrifugation.  PB was previously administered  to rats and crude 
lysosome fractions  prepared from leupeptin-treated  (A)  and un- 
treated (B) rat livers were subjected to Percoll density gradient cen- 
trifugation. Gradients were collected in fractions of 1 ml each, and 
the autolysosome fractions with a density of 1.13-1.15 were analysed 
for acid phosphatase activity (o) and P-450(PB) antigen (o). The 
latter  was measured  by quantitative  immunoblot  analysis  as de- 
scribed in Materials and Methods. The corresponding immtmoblot 
patterns of P-450(PB) in the autolysosome fractions together with 
that of purified  P-450(PB) (arrow) are shown at the bottom of A 
and B. 
The specific content of P-450(PB) in the cytosol fraction 
was only --0.16 and 0.59% of those in the microsome frac- 
tion from PB-treated and untreated rat livers, respectively. 
Effect of  PB on the Protein and P-450(PB) 
Contents in Microsorae and Autolysosome Fractions 
Fig.  6  shows the changes in the protein contents of micro- 
some and autolysosome fractions during and after PB treat- 
ment.  Repeated injections of PB led to the increase in the 
microsomal protein corresponding to the proliferation of the 
smooth ER. After cessation of PB treatment, the microsomal 
proteins decreased dramatically to the control level within 
7  d  as previously reported (15). The protein content in the 
autolysosome fraction did not increase during PB treatment 
but showed marked increase (,,,,60%) on the third day after 
cessation of PB treatment when microsomal proteins were 
rapidly decreasing. This result suggests that the increase in 
the autophagic activity may be responsible for the removal 
of PB-induced ER membranes. 
To determine  whether  induction  of lysosomal enzymes 
Figure  5. SDS PAGE  and immunoblot analyses of  the autolysosome 
fraction  from PB-treated  and untreated  rat livers.  The autolyso- 
somal proteins from PB-treated (.4, lane 1; B, lanes 1 and 3) and 
untreated (A, lane 2; B, lanes 2 and 4) rat livers were separated on 
SDS PAGE and stained with Coomassie Brilliant Blue (A), or im- 
munoblotted using anti-P-450(PB) (B, lanes 1 and 2) and anti-FP2 
(B, lanes 3 and 4) antibodies. Numbers in the center are molecular 
mass in kiledaltons. 
occurred  during  and  after PB  treatment,  the  activities  of 
cathepsin D and acid phosphatase were determined. The spe- 
cific activities of the two enzymes in both the homogenate 
and autolysosome fractions were constant throughout the ex- 
perimental period (data not shown). 
Next, the levels of P-450(PB) in the microsome and au- 
tolysosome fractions were measured during  and after PB- 
treatment (Fig. 7). Increase in the specific contents of micro- 
somal P-450(PB)  was much more remarkable than that of 
microsomal proteins and the specific contents of P-450 (PB) 
segregated  in  the  autolysosomes  ran  parallel  to  those  in 
the microsomes. 
Ferritin lmmunoelectron Microscopy of  the 
Autolysosomes Prepared  from PB-treated and 
Untreated Rats 
Ferritin  immunoelectron microscopic techniques  were ap- 
plied to directly demonstrate the segregation of P-450(PB) of 
Table II. Specific Contents of  P-450(PB) and FP2 
Determined by lmmunoblot Analysis in Microsome (Ms) 
and Auto~ysosome (Al) Fractions Prepared from PB-treated 
and Untreated Rat Livers 
PB  P-450(PB)  FP2 
Fraction  treatment  pmol/mg protein  pmol/mg protein 
--  42  +  16  37  +  14  Ms 
+  623  5:  120  96  :t:  21 
-  3-I-0  2+1 
A1 
+  31+10  4+1 
Values are expressed as the mean :t: SD (n  =  3). 
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Figure 6. Changes in microsomal and autolysosomal proteins per 
gram of liver during and after PB treatment. Rats were given an in- 
traperitoneal  injection of PB (80 mg/kg body wt) daily for 4 d as 
indicated by arrowheads. The amount of microsomal (e) and au- 
tolysosomal (o) proteins were determined. All values are mean + 
SD; n  =  3. 
ER membranes because previous studies from this labora- 
tory (17) have shown that the antibodies used recognize the 
cytoplasmic domains  of P-450(PB).  Figure  8  a  shows  an 
electron micrograph of an autolysosome fraction from PB- 
treated rat liver after incubation with ferritin antibody con- 
jugates against P-450(PB). The mature autolysosomes com- 
pletely covered by the limiting membranes were not stained 
at all by ferritin particles. In marked contrast,  autophago- 
somes and premature autolysosomes are fragile and when 
their limiting membranes were partially broken, as shown in 
Fig.  8 a, a number of ferritin particles were seen attached 
to the smooth vesicles segregated within the premature au- 
tolysosomes. The density of the ferritin particles attached to 
these smooth vesicles was comparable to that of the micro- 
somal membranes prepared from PB-treated rat. 
Fig. 8 b shows an electron micrograph of the autolysosome 
fraction prepared from a PB-untreated rat. It is evident that 
the smooth vesicles in the premature autolysosomes are stud- 
ded with much less ferritin particles than those from a PB- 
treated rat. Although the limiting membranes are apparently 
not broken in this plane of sectioning, they are presumably 
broken in another plane. 
As shown in Fig. 8 c, practically no ferritin particles bound 
to the smooth vesicles when incubated with the control con- 
jugates.  The  ferritin  particles  attached  to  the  amorphous 
materials (arrows) in the broken premature autolysosomes 
are nonspeeifically binding. 
These results clearly demonstrate that the ER membranes 
containing P-450(PB) were in fact segregated into the auto- 
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Figure  7.  Changes  in the  specific contents of P-450(PB)  in the 
microsome and autolysosome fractions. After immunoblotting, the 
contents of P-450(PB) in the microsomes (e) and autolysosomes 
(o) were determined quantitatively as described in Materials and 
Methods.  All values are mean -1- SD; n  =  3. 
lysosomes. It is to be noted here that no ferritin particles 
were attached to the limiting membranes of the autolyso- 
somes, regardless of their integrity and maturity. This topic 
will be the focus of a subsequent report. (Yamamoto, A., R. 
Masaki, and Y. Tashiro, manuscript in preparation.) 
Discussion 
We isolated autolysosomes from PB-treated and untreated 
rats according to Furuno et al. (6) and found, using immuno- 
blot analysis, that both P-450 (PB) and FP2 were detected 
there in large amounts; the specific contents of these two pro- 
teins in the autolysosome fraction was ~5% of those in the 
microsomes (Table II). These two proteins recovered in the 
autolysosome fraction could not be attributed to the contami- 
nation by ER membranes. Enzymatic (Table I) and morpho- 
logical  (Fig.  2)  characterization  of the  isolated  autolyso- 
somes indicated that the contamination of the autolysosome 
fractions by ER  membranes is  negligible.  Assuming  that 
G-6-Pase and FP2 are exclusively localized in the ER mem- 
branes and that the microsomes are derived from ER mem- 
branes,  the contamination of the autolysosome fraction by 
ER membranes can be estimated from the enzyme activities 
of G-6-Pase and FP2 in the latter fraction to be '~0.4% on 
the average (Table I). 
Thus  there  is  a  big  discrepancy  in  the  amount  of the 
microsomal membrane proteins in the autolysosome fraction 
Figure 8. Electron micrographs of autolysosome fraction incubated with ferritin-antibody conjugates against P-450(PB) (a and b) or control 
conjugates (c). The autolysosome fractions were prepared from PB-treated (a and c) and untreated (b) rat livers. In a and b some of the 
small vesicles heavily studded with ferritin particles appear to be released out of these premature autolysosomes (PAL) through holes of 
the limiting membranes. Note that the cytoplasmic surfaces of the limiting membranes of neither the premature (PAL) nor the mature au- 
tolysosomes (MAL) are stained with ferritin particles.  The small arrows in c indicate nonspecific binding of ferritin control conjugates 
to the residual materials.  Bars, 0.5 gm. 
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(•0.4  %) and from the immunoblot assays of P-450 (PB) and 
FP2  (*5%).  The most probable explanation for this dis- 
crepancy is that microsomal P-450 (PB) and FP2 are segre- 
gated to be degraded in the autolysosomes, but inhibition of 
lysosomal thiol proteases by leupeptin treatment might have 
led to the marked accumulation of immunoreactive, but en- 
zymatically inactive, P-450(PB)  and FP2 molecules in the 
autolysosomes. Some of the enzyme molecules segregated in 
the autolysosomes, especially in the premature ones, could 
be enzymatically active and may contribute to the enzyme 
activities found in the autolysosome fraction. The degree of 
contamination by the ER membranes of the autolysosome 
fraction estimated from the two marker enzyme activities, 
therefore, could be much less than the estimated value of 
0.4%. 
The present ferritin immunoelectron microscopic obser- 
vations clearly revealed that the smooth vesicles segregated 
within the premature autolysosomes when the limiting mem- 
branes were broken are heavily stained with ferritin antibody 
conjugates (Fig.  8).  The immunoelectron microscopic ob- 
servations using a postembedding protein A-colloidal gold 
method, however,  clearly demonstrated that when treated 
with leupeptin P-450(PB)  was detected not only in the pre- 
mature autolysosomes but also in the mature autolysosomes 
in the rat hepatocyte. 
As shown in Table II and Fig. 5, P-450(PB)  and FP2 were 
detected in the autolysosomes  prepared from both PB-treated 
and untreated rat livers.  These results strongly suggest that 
the autophagic process is responsible for the degradation of 
these enzymes regardless of PB treatment. That is, this pro- 
cess is likely to be a normal cellular process responsible for 
the degradation of the two ER membrane proteins. The in- 
crease in the amount of autolysosomal proteins at 3 d after 
cessation of PB treatment may indicate accelerated auto- 
phagocytosis in this special period. 
Three possible routes could be suggested for degradation 
of the ER membrane proteins such as P-450 and FP2. The 
first is that the ER membrane proteins are transported to the 
lysosomal compartment via the Golgi apparatus to be de- 
graded there.  In the previous paper  (29)  we  showed that 
P-450(PB)  was not detectable on the membrane of Golgi cis- 
ternae either when P-450(PB) was maximally induced by PB 
treatment or when P-450 content in the microsomes rapidly 
decreased after cessation of the treatment. This route, there- 
fore, could be ruled out. 
The second is ER membrane proteins are released to the 
cytosol, then degraded either directly in the cytosol compart- 
ment or further sequestered to be degraded in the autoly- 
sosomes.  Sequestration of several cytosolic proteins in an 
autophagosome-autolysosome system was clearly shown by 
Kominami et al. (10). In fact, we found a very small amount 
of P-450(PB) in the cytosol fractions. The possible participa- 
tion of this route, therefore, can not be neglected at the pres- 
ent time. 
The third is that ER membranes are directly segregated 
and then degraded in the autophagosome-antolysosome sys- 
tem. In this report we have demonstrated biochemical and 
immunoelectron microscopic evidences that convincingly 
show the existence of large amounts of P-450(PB)  and FP2 
associated with ER membranes in the autolysosomes. 
Our results strongly suggest that the autophagosome-auto- 
lysosome system plays a very important role in the degra- 
dation of P-450(PB)  and FP2.  Recently, the half-lives of 
microsomal enzymes, including various molecular forms of 
P-450, have been reported by several investigators (18, 21, 24, 
26, 27). The wide differences in the half-lives of microsomal 
enzymes, ranging from 3-4 h to >10 d were interpreted not 
to support the major contribution of the autophagic process 
to the degradation of ER enzymes in the liver cells (21, 24, 
26, 27). This is because the autophagic digestion of  the mem- 
branes as a whole will result in the uniform turnover rate of 
various  microsomal  enzymes  if they  are  uniformly dis- 
tributed in the ER membranes and no sorting of the mem- 
brane proteins occurs in the autophagic process. 
A morphometric analysis of the content of the autolyso- 
somes by Bolender and Weibel (3), however, showed that the 
ER  membranes  were  preferentially segregated  there  and 
from this they concluded that the formation of  autolysosomes 
was not a random process. It is possible that such a sorting 
mechanism also works at the level of the ER membrane pro- 
teins, preferentially segregating some membrane proteins, 
thus facilitating their degradation. 
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